Source: Annual Congress 2008 - Basic science in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. C. M. Simoes, G. Xanthou, K. Petrochilou, V. Panoutsakopoulou, C. Roussos, C. Gratziou (Athens, Greece). Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma. Eur Respir J 2008; 32: Suppl. 52, 3564

Member's Comments

No comment yet.

Related content which might interest you: Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 Effect of bronchial neutrophilia on airway remodeling in asthma Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation Year: 2006 Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001 Autoimmunity  in airway inflammation and asthma Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017 Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Allergen-induced airway remodelling Source: Eur Respir J 2007; 29: 1020-1032 Year: 2007 Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Are we ready to monitor inflammation and remodelling in asthma? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 ADAM33 is involved in post-natal airway hyperresponsiveness caused by maternal allergic airway inflammation Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools Year: 2018 The role of small-airway inflammation and remodeling in asthma Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance Year: 2013 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019